Symbol
| KDM2B
| contributors: mct - updated : 24-11-2011
|
HGNC name
| lysine (K)-specific demethylase 2B
|
HGNC id
| 13610
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
|  
| --over
|  
|
in various human leukemias | |
Variant & Polymorphism
|
| |
Candidate gene
Marker
Therapy target
|
System | Type | Disorder | Pubmed |
cancer | | | |
silencing KDM2B can help overcome resistant cancer cells for pro-apoptotic therapies |
| | | |
| about half of Fbxl10-deficient mice exhibit failure of neural tube closure, resulting in exencephaly and die shortly after birth |